Consolidated Statements of Operations - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Cost of product sales |
$ 2,720
|
$ 8,687
|
| Net product revenue |
13,957
|
6,369
|
| Gross profit (loss) |
11,237
|
(2,318)
|
| Operating expenses: |
|
|
| Sales and marketing |
30,677
|
30,524
|
| General and administrative |
16,662
|
11,937
|
| Research and development |
3,630
|
2,398
|
| Total operating expenses |
50,969
|
44,859
|
| Loss from operations |
(39,732)
|
(47,177)
|
| Other (expense) income, net: |
|
|
| Change in fair value of warrant liability and derivative, net |
12,508
|
66,891
|
| Interest income |
2
|
25
|
| Interest expense |
(15,895)
|
(15,394)
|
| Litigation settlement |
2,500
|
0
|
| Total other (expense) income, net |
(885)
|
51,522
|
| Net (loss) income before income taxes |
(40,617)
|
4,345
|
| Provision for income taxes |
0
|
0
|
| Net (loss) income |
(40,617)
|
4,345
|
| Net loss attributable to common stockholders, basic (Note 14) |
(40,205)
|
(10,336)
|
| Net loss attributable to common stockholders, diluted (Note 14) |
$ (40,205)
|
$ (69,963)
|
| Net loss per common share, basic |
$ (5.72)
|
$ 0
|
| Net loss per common share, diluted |
$ (5.72)
|
$ (8.20)
|
| Weighted-average common shares used in net loss, basic (Note 14) |
7,027,860
|
0
|
| Weighted-average common shares used in net loss, diluted (Note 14) |
7,027,860
|
8,529,846
|